Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Àngel Rivero
Observed names:
Angel Rivero,
Rivero Calaf, Angel,
Àngel Rivero Calaf,
Ángel Rivero
Institutions:
Hospital Universitari Germans Trias i Pujol,
Fundació Lluita contra les Infeccions
Observed institutions:
Hospital Universitario 12 De Octubre,
Corporació Sanitària Parc Taulí,
Hospital Universitari Germans Trias i Pujol,
Fundació Lluita contra les Infeccions
ORCID:
0000-0003-2136-0702
Observed ORCID:
0000-0003-2136-0702
OpenAlex ID:
A5024740925
Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
2022
·
Eloy José Tarín-Vicente
, Andrea Alemany
, et al.
·
The Lancet
·
709
PDF
Viral Dynamics in Patients with Monkeypox Infection: A Prospective Cohort Study in Spain
2022
·
Clara Suñer
, Maria Ubals
, et al.
·
The Lancet Infectious Diseases
·
174
PDF
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trial
2022
·
Lucia Bailón
, Anuska Llano
, et al.
·
Nature Medicine
·
73
PDF
Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study
2024
·
Igor Moraes-Cardoso
, Susana Benet
, et al.
·
The Lancet Microbe
·
47
Oral linezolid compared with benzathine penicillin G for treatment of early syphilis in adults (Trep-AB Study) in Spain: a prospective, open-label, non-inferiority, randomised controlled trial
2024
·
Maria Ubals
, Patricia Nadal-Baron
, et al.
·
The Lancet Infectious Diseases
·
34
PDF
Evaluating the Accuracy of Self-Collected Swabs for the Diagnosis of Mpox
2022
·
Maria Ubals
, Eloy José Tarín-Vicente
, et al.
·
Clinical Infectious Diseases
·
17
PDF
Impact of Dolutegravir Plus Lamivudine as First-line Antiretroviral Treatment on the Human Immunodeficiency Virus Type 1 Reservoir and Inflammatory Markers in Peripheral Blood
2024
·
Lucía Bailón
, Maria C Puertas
, et al.
·
The Journal of Infectious Diseases
·
13
PDF
Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy
2025
·
Maria C. Puertas
, Lucía Bailón
, et al.
·
PLoS Pathogens
·
9
PDF
Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona
2023
·
Francesc López Seguí
, Unai Oyón Lerga
, et al.
·
PLoS ONE
·
9
PDF
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
2026
·
Amy E Colson
, Princy N Kumar
, et al.
·
The Lancet
·
7
Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection
2023
·
İbrahim Sönmez
, Héctor Martínez Riveros
, et al.
·
Sexually Transmitted Infections
·
6
PDF
Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populations
2026
·
Josep M Llibre
, Carlos Iniesta
, et al.
·
Journal of Antimicrobial Chemotherapy
·
5
Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program
2025
·
Lucia Bailón
, Yovaninna Alarcón-Soto
, et al.
·
Open Forum Infectious Diseases
·
4
PDF
Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)
2025
·
Juan Ambrosioni
, Elisa de Lazzari
, et al.
·
Journal of Infection
·
3
PDF
Target Trial Emulation of the Modified Vaccinia Ankara-Bavarian Nordic Vaccine for Pre-Exposure Mpox Prevention in At-Risk Populations
2025
·
Clara Suñer
, Roser Escrig-Sarreta
, et al.
·
Vaccines
·
3
PDF
Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol
2025
·
Eugenia Negredo
, Diana Hernández-Sánchez
, et al.
·
BMJ Open
·
2
Primary bone lymphoma: Report of 7 cases
2018
·
Neus Muñoz
, Àngel Rivero Calaf
, et al.
·
Medicina Clínica (English Edition)
·
2
Baseline resistance mutations and virological response to dolutegravir in treatment-naïve patients: a multicentre NGS study
2026
·
Alexy Inciarte
, Leire Berrocal
, et al.
·
Journal of Antimicrobial Chemotherapy
·
1
HCV infection, risk factors and PrEP use among HIV-negative MSM and TW at a community health centre
2025
·
Àngel Rivero
, Albert Dalmau-Bueno
, et al.
·
Journal of Infection and Public Health
·
1
Linfoma óseo primario: estudio de 7 casos
2018
·
Neus Muñoz
, Àngel Rivero Calaf
, et al.
·
Medicina Clínica
·
1
First-line dolutegravir/lamivudine in HIV-1 infection: lymph node penetration and reservoir decline in a randomized open-label clinical trial
2026
·
Elias P. Rosen
, Stephen Bondoc
, et al.
·
Nature Communications
PDF
Colaborando en la protección del medio ambiente mediante la dispensación automatizada de medicamentos
2026
·
Valero Valdelvira, Patricia
, Davins Riu, Meritxell
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Evaluation of dual path platform optical density in relation to RPR titers and serological response in syphilis: a cross-sectional and longitudinal study
2026
·
Sara Buezo
, Roser Escrig-Sarreta
, et al.
·
International Journal of Infectious Diseases
PDF
Incidence and Clinical, Virological, and Resistance Characteristics of HIV Infections Among pre-Exposure Prophylaxis Users in Spain (SCOPE Study): A Multicentre Prospective and Retrospective Cohort Study
2026
·
Mar Vera
, Patricia Álvarez-López
, et al.
·
The Lancet Regional Health - Europe
Parálisis periódica hipopotasémica tirotóxica, a propósito de un caso
2018
·
José León
, Neus Muñoz
, et al.
·
Medicina Clínica
Show more works
View as search
Works count:
26
Citation count:
1,133
H-index:
9
I10-index:
8
Year
Topic
Type